Given the following information, prepare a trial balance for Pfizer Inc. as of December 31, 2024:

Account	Debit ($)	Credit ($)
Cash	$240,852,000
Accounts Receivable	$245,963,000
Inventory	$220,741,000
Equipment	$880,000,000
Accumulated Depreciation		$410,789,000
Accounts Payable		$360,456,000
Notes Payable		$800,654,000
Common Stock		$950,321,000
Retained Earnings		$443,000,000
Sales Revenue		$1,050,000,000
Cost of Goods Sold	$525,000,000
Operating Expenses	$370,000,000